2016 Section 5 Green Book

Luk et al.

TABLE 3. Comparison of mean baseline SF-6D health state utility values between treatment modality across patient characteristics *

Baseline characteristics

Medical management (n = 40)

Surgical intervention (n = 152)

Treatment crossover (n = 20)

p

Age (years)

18–40 (n = 38) 41–60 (n = 95) 61–86 (n = 59)

0.76 ± 0.14 0.73 ± 0.13 0.80 ± 0.07 0.76 ± 0.12 0.75 ± 0.13 0.72 ± 0.12 0.80 ± 0.11 0.75 ± 0.14 0.77 ± 0.10 0.72 ± 0.11 0.77 ± 0.12 0.63 ± 0.05 0.77 ± 0.12 0.73 ± 0.16 0.77 ± 0.10 0.85 ± 0.09 0.75 ± 0.12 0.81 ± 0.14 0.74 ± 0.11 0.79 ± 0.11 0.74 ± 0.12 0.68 ± 0.14 0.77 ± 0.12 0.0 ± 0.0 0.76 ± 0.12 0.77 ± 0.11 0.74 ± 0.14

0.69 ± 0.14 0.69 ± 0.14 0.73 ± 0.15 0.73 ± 0.15 0.67 ± 0.14 0.69 ± 0.16 0.71 ± 0.13 0.72 ± 0.15 0.69 ± 0.14 0.69 ± 0.14 0.71 ± 0.15 0.66 ± 0.14 0.71 ± 0.14 0.69 ± 0.16 0.71 ± 0.14 0.63 ± 0.11 0.71 ± 0.15 0.70 ± 0.14 0.70 ± 0.15 0.72 ± 0.15 0.69 ± 0.15 0.60 ± 0.09 0.72 ± 0.15 0.68 ± 0.10 0.70 ± 0.15 0.74 ± 0.14 0.66 ± 0.14

0.77 ± 0.04 0.63 ± 0.13 0.73 ± 0.14 0.73 ± 0.14 0.65 ± 0.13 0.72 ± 0.14 0.69 ± 0.14 0.68 ± 0.15 0.71 ± 0.12 0.69 ± 0.14 0.70 ± 0.14 0.68 ± 0.15 0.71 ± 0.13 0.76 ± 0.05 0.69 ± 0.14 0.72 ± 0.13 0.69 ± 0.14 0.64 ± 0.16 0.73 ± 0.11 0.57 ± 0.07 0.71 ± 0.13 0.8 ± – 0.69 ± 0.14

0.318

0.146

0.316

Gender Male

0.666

Female

0.067

Previous sinus surgery Present

0.749

Absent

0.042

Nasal polyposis Present

0.563

Absent

0.036

Deviated septum Present

0.680

Absent

0.122

Turbinate hypertrophy Present

0.573

Absent

0.054

Asthma

Present

0.614

Absent

0.078

Aspirin sensitivity Present

0.021

Absent

0.268

Allergies (history) Present

0.192

Absent

0.221

Allergies (mRAST confirmed) Present

0.061

Absent

0.271

Depression Present

0.283

Absent

0.263

Current smoker Present

–

–

Absent

0.70 ± 0.14

0.079

Alcohol consumption Present

0.70 ± 0.12 0.70 ± 0.15

0.413

Absent

0.081

* Values are mean ± SD. mRAST = modified radioallergosorbent testing; SD = standard deviation; SF-6D = Medical Outcomes Study Short Form-6D.

International Forum of Allergy & Rhinology, Vol. 00, No. 00, xxxx 2015

115